Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.39
Delayed Data
As of May 26
 +0.05 / +2.14%
Today’s Change
1.93
Today|||52-Week Range
3.77
+12.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues21.0M53.6M66.5M45.4M
 
 
 
 
 
Cost of Goods Sold----4.1M2.6M
 
 
 
Depreciation And Amortization--6.0M6.0M6.0M
 
 
 
 
 
Operating ExpensesGross Income----56.4M36.9M
 
 
 
General Expenses7.0M12.3M15.0M16.9M
 
 
 
 
 
Research And Development--1.9M1.9M1.8M
 
 
 
 
Total Operating Expenses7.0M18.4M25.1M25.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income14.1M35.3M41.4M19.9M
 
 
 
 
 
Extraordinary Credit0.00--5.8M0.00
 
 
Extraordinary Charge-3.0M-2.6M-57.2M-1.4M
 
 
 
 
 
Interest Expense On Debt4.5M4.5M4.7M5.0M
 
 
 
 
 
Other Expenses129.0K162.0K184.0K212.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.8M28.3M-14.6M13.7M
 
 
 
 
 
Income Taxes-2.7M-14.4M-4.3M-6.6M
 
 
 
 
 
Minority Interest0.00-3.0K-56.0K-47.0K
 
 
 
 
Net Income4.1M13.9M-10.3M7.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS163.8M163.9M164.0M163.7M
 
 
 
 
 
Shares To Calculate EPS Diluted164.0M164.3M164.5M164.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.03$0.08-$0.06$0.04
 
 
 
 
 
EPS Diluted$0.03$0.08-$0.06$0.04